Prostate-specific membrane antigen antibody-drug conjugate

· Progenics Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Prostate-specific membrane antigen antibody-drug conjugate, covering 2013-11-01 to 2013-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer [Phase 1]

See pricing